Related Experiment Video
Updated: Jul 2, 2025

05:25
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
710
Effect of on-pump vs. off-pump coronary artery bypass grafting in patients with non-dialysis-dependent severe renal
Daniel P Fudulu1, Amerikos Argyriou1, Rahul Kota2
1Department of Cardiac Surgery, Bristol Heart Institute, University of Bristol, Bristol, United Kingdom.
Frontiers in Cardiovascular Medicine
|February 28, 2024
Summary
Off-pump coronary artery bypass grafting (OPCABG) and on-pump coronary artery bypass grafting (ONCABG) show similar early mortality and stroke rates in patients with severe renal impairment. ONCABG increases the risk of bleeding and hospital stay.
Area of Science:
- Cardiovascular Surgery
- Nephrology
- Clinical Outcomes Research
Background:
- On-pump coronary artery bypass (ONCABG) grafting poses risks for patients with poor renal reserve.
- Evidence on off-pump coronary artery bypass (OPCABG) benefits in high-risk renal patients is limited and controversial.
- Severe renal impairment (creatinine clearance < 50 mL/min) significantly increases perioperative morbidity and mortality.
Purpose of the Study:
- To compare early clinical outcomes between OPCABG and ONCABG in patients with severe renal impairment.
- To utilize propensity-matched cohorts from a large national registry for robust comparison.
- To assess the impact of surgical technique on mortality, stroke, dialysis, bleeding, and hospital stay.
Main Methods:
- Retrospective analysis of 8,628 patients with severe renal impairment undergoing isolated CABG (1996-2019) from the UK NACSA database.
- Propensity score matching (1:1 nearest neighbor) to create comparable cohorts for OPCABG (n=1,141) and ONCABG (n=1,141).
- Cluster-robust standard error regression used for outcome analysis, adjusting for baseline characteristics.
Main Results:
- No significant differences in in-hospital mortality, post-operative dialysis, or stroke rates between OPCABG and ONCABG groups.
- ONCABG group showed a higher rate of return to theatre for bleeding or tamponade (P > 0.02).
- OPCABG was associated with a shorter hospital length of stay by 1 day (P = 0.008).
Conclusions:
- OPCABG and ONCABG demonstrate comparable early mortality and stroke rates in patients with severe renal impairment.
- ONCABG is linked to an increased risk of bleeding complications requiring reoperation.
- OPCABG may offer a benefit in reducing hospital length of stay for this high-risk population.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375

